Developmental Alterations in Adult-Onset Neurodegenerative Disorders: Lessons from Polyglutamine Diseases.
作者信息
Edamakanti Chandrakanth Reddy, Opal Puneet
机构信息
Davee Department of Neurology, Northwestern University Feinberg School of Medicine Chicago, Chicago, IL, USA.
出版信息
Mov Disord. 2021 Jul;36(7):1548-1552. doi: 10.1002/mds.28657. Epub 2021 May 20.
Abstract
摘要
相似文献
1
Developmental Alterations in Adult-Onset Neurodegenerative Disorders: Lessons from Polyglutamine Diseases.成人起病的神经退行性疾病中的发育改变：来自多聚谷氨酰胺疾病的教训
Mov Disord. 2021 Jul;36(7):1548-1552. doi: 10.1002/mds.28657. Epub 2021 May 20.
2
Targeting protein aggregation in neurodegeneration--lessons from polyglutamine disorders.针对神经退行性疾病中的蛋白质聚集——来自多聚谷氨酰胺疾病的经验教训。
Expert Opin Ther Targets. 2006 Aug;10(4):505-13. doi: 10.1517/14728222.10.4.505.
3
[Therapeutic strategies for the polyglutamine diseases].[聚谷氨酰胺疾病的治疗策略]
Brain Nerve. 2007 Apr;59(4):393-404.
4
Protective effect of chaperones on polyglutamine diseases.伴侣蛋白对多聚谷氨酰胺疾病的保护作用。
Brain Res Bull. 2001;56(3-4):165-8. doi: 10.1016/s0361-9230(01)00593-7.
5
Autophagy and polyglutamine diseases.自噬与多聚谷氨酰胺疾病。
Prog Neurobiol. 2012 May;97(2):67-82. doi: 10.1016/j.pneurobio.2011.08.013. Epub 2011 Sep 10.
6
[Role of chromatin alterations in neurodegeneration induced by polyglutamine-expanded ataxin-7].
Med Sci (Paris). 2006 Aug-Sep;22(8-9):700-2. doi: 10.1051/medsci/20062289700.
7
[Mechanisms of neurodegeneration in polyglutamine diseases].[多聚谷氨酰胺疾病中的神经退行性变机制]
Rinsho Shinkeigaku. 2003 Nov;43(11):901-2.
8
Current understanding on the pathogenesis of polyglutamine diseases.目前对多聚谷氨酰胺疾病发病机制的认识。
Neurosci Bull. 2010 Jun;26(3):247-56. doi: 10.1007/s12264-010-0113-2.
9
Therapeutic opportunities in polyglutamine disease.聚谷氨酰胺疾病的治疗机遇
Nat Med. 2001 Apr;7(4):419-23. doi: 10.1038/86486.
10
[Molecular biology of polyglutamine diseases].[多聚谷氨酰胺疾病的分子生物学]
Postepy Hig Med Dosw. 2002;56(6):779-88.
引用本文的文献
1
Bridging the gap: insights into sensorimotor deficits in NMDA receptor antibody encephalitis.缩小差距：对NMDA受体抗体脑炎感觉运动缺陷的见解。
J Clin Invest. 2025 Mar 3;135(5):e188251. doi: 10.1172/JCI188251.
2
Reactive Bergmann glia play a central role in spinocerebellar ataxia inflammation via the JNK pathway.反应性 Bergmann 胶质细胞通过 JNK 通路在脊髓小脑共济失调炎症中发挥核心作用。
J Neuroinflammation. 2023 May 26;20(1):126. doi: 10.1186/s12974-023-02801-1.
本文引用的文献
1
Glia in Neurodegeneration: The Housekeeper, the Defender and the Perpetrator.神经退行性变中的神经胶质：管家、捍卫者和始作俑者。
Int J Mol Sci. 2020 Dec 2;21(23):9188. doi: 10.3390/ijms21239188.
2
Huntington's Disease: Les Jeux Sont Faits?亨廷顿病：游戏结束了吗？
Trends Mol Med. 2020 Oct;26(10):889-890. doi: 10.1016/j.molmed.2020.08.004. Epub 2020 Sep 4.
3
Huntington's disease alters human neurodevelopment.亨廷顿舞蹈症会改变人类神经发育。
Science. 2020 Aug 14;369(6505):787-793. doi: 10.1126/science.aax3338. Epub 2020 Jul 16.
4
MR imaging and spectroscopy in degenerative ataxias: toward multimodal, multisite, multistage monitoring of neurodegeneration.MR 成像和光谱在变性共济失调中的应用：实现神经退行性变的多模态、多部位、多阶段监测。
Curr Opin Neurol. 2020 Aug;33(4):451-461. doi: 10.1097/WCO.0000000000000834.
5
The contribution of glial cells to Huntington's disease pathogenesis.神经胶质细胞在亨廷顿病发病机制中的作用。
Neurobiol Dis. 2020 Sep;143:104963. doi: 10.1016/j.nbd.2020.104963. Epub 2020 Jun 25.
6
Abnormal development of cerebellar-striatal circuitry in Huntington disease.亨廷顿病小脑-纹状体回路的异常发育。
Neurology. 2020 May 5;94(18):e1908-e1915. doi: 10.1212/WNL.0000000000009364. Epub 2020 Apr 7.
7
The pathobiology of perturbed mutant huntingtin protein-protein interactions in Huntington's disease.亨廷顿病中突变型亨廷顿蛋白-蛋白相互作用失调的病理生物学。
J Neurochem. 2019 Nov;151(4):507-519. doi: 10.1111/jnc.14853. Epub 2019 Sep 15.
8
Abnormal brain development in child and adolescent carriers of mutant huntingtin.突变亨廷顿蛋白携带者的儿童和青少年的异常大脑发育。
Neurology. 2019 Sep 3;93(10):e1021-e1030. doi: 10.1212/WNL.0000000000008066. Epub 2019 Aug 1.
9
Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription.突变亨廷顿蛋白损害 PNKP 和 ATXN3，破坏 DNA 修复和转录。
Elife. 2019 Apr 17;8:e42988. doi: 10.7554/eLife.42988.
10
Brain Derived Neurotrophic Factor (BDNF) Delays Onset of Pathogenesis in Transgenic Mouse Model of Spinocerebellar Ataxia Type 1 (SCA1).脑源性神经营养因子（BDNF）延缓1型脊髓小脑共济失调（SCA1）转基因小鼠模型发病机制的 onset（此处onset可能有误，推测应为“发病”）。
Front Cell Neurosci. 2019 Jan 21;12:509. doi: 10.3389/fncel.2018.00509. eCollection 2018.
Zotero 插件